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Abstract 
Protein glycation induces structural and stability changes that impair protein function, 
and is associated with several human neurodegenerative diseases, such as Alzheimer’s disease, 
Parkinson’s disease and Familial Amyloidotic Polyneuropathy. Recently we have shown that 
methylglyoxal induces and stabilizes the formation of small native-like aggregates in the 
amyloidogenic protein insulin and the same was previously shown for α-synuclein. However, 
the fundamental biophysical mechanism underlying such methylglyoxal-induced protein 
aggregation is not yet fully understood. In this study, we used the model protein cytochrome c 
to characterize the specific glycation targets and to investigate the glycation effects on protein 
structure, stability and aggregation. Methylglyoxal was found modify cytochrome c in a single 
residue and to induce the formation of cytochrome c native-like aggregates. Additionally, it is 
shown that methylglyoxal glycation of cytochrome c also results in the formation of a partially 
unfolded species. Interestingly, the formation of this partially unfolded species is not 
implicated in the aggregation process, a clear difference from amyloid fibril mechanisms that 
involve partially or totally unfolded intermediates. Equilibrium-unfolding experiments using 
guanidinium hydrochloride shows that glycation strongly reduces cytochrome c 
conformational stability. This reduction is balanced by aggregation that increases 
conformational stability. The data collected from analytical and spectroscopic techniques along 
with kinetic analysis based on least-squares parameter fitting and statistical model 
discrimination permitted the proposal of a comprehensive thermodynamic and kinetic model 
for native-like aggregation of methylglyoxal glycated cytochrome c. 
 
Keywords: Native-like aggregation, Conformational diseases, Glycation, Methylglyoxal, 
Cytochrome c  
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Importance of the work: The manuscript presents important data on the molecular 
mechanisms of protein aggregation induced by glycation, which has been associated to several 
human neurodegenerative diseases. Our major findings show that glycation induces protein 
native-like aggregation and that the aggregation process is thermodynamic and kinetically 
favored. These results may be extended to the aggregation behaviour of amyloidogenic 
proteins upon glycation, suggesting a shift from an amyloidogenic pathway to a native-like 
aggregation process. 
 
Abbreviations Used: α-CHCA: α-cyano-4-hydroxicinamic acid, ACN: Acetonitrile, AGE: 
Advanced glycation end-products; AIC: Akaike Information Criteria, CD: Circular dichroism, CID: 
Collision induced dissociation, GdnHCl: Guanidinium hydrochloride, MAGE: Methylglyoxal-
derived advanced glycation end-products, MGH: Hydroimidazolone, MALDI: Matrix-assisted 
laser-desorption ionization, SEC: Size exclusion chromatography, TOF: Time of flight 
Introduction 
More than 40 human diseases are associated with the deposition of normally soluble 
and functional proteins into insoluble aggregates having well-defined morphological, structural 
and tinctorial properties (1). These include a long and unbranched shape when fibrils are 
analyzed with transmission electron microscopy (2) or atomic force microscopy (3), the ability 
to bind specific dyes (4; 5) and a typical cross-β pattern, when analyzed by X-ray diffraction (2). 
Many of these diseases involve protein aggregation due to genetic mutations, abnormal 
proteolysis or post-translational modifications in disease-related proteins. Among the different 
known post-translational modifications, protein glycation has gained increased attention in the 
context of several human pathologies, such as age-related disorders and neurodegenerative 
diseases of amyloid type. In this irreversible post-translational modification, protein amino 
groups (N-terminal and arginine and lysine side chains) are modified by carbonyl compounds 
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leading to the formation of advanced glycation end-products (AGE). Methylglyoxal, a non-
enzymatic by-product of dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate 
production during glycolysis in eukaryotic cells, is the main intracellular glycation agent, 
reacting with amino groups in lipids, nucleic acids and proteins with the formation of 
methylglyoxal-derived advanced glycation end-products (MAGE) (6). Protein glycation has 
been reported in numerous neurodegenerative diseases to be involved in amyloidosis (7-11) 
and several studies suggest that glycation may be an early event in protein aggregation (10; 12; 
11). Moreover, recent studies showed that glycation by methylglyoxal resulted in inhibitory 
effects on the formation and extension of fibrils and in the stabilization of native-like 
oligomeric species (13; 14). The formation of these aggregates in vivo may be a key step for 
cellular damage, cytotoxicity and neurotoxicity, as increasing evidence shows that the severity 
of cognitive impairment in protein misfolding diseases correlates with the levels of small 
oligomeric species and not with the large amyloid fibrils (15-18). 
The propensity of normally folded proteins to form amyloid-like fibrils increases in 
conditions that favor the partial unfolding of the native state across the major unfolding 
energy barrier. These include low pH, high temperature, or the presence of organic solvents 
(19-21). However increasing evidence is now accumulating that folded proteins also retain a 
significant tendency to aggregate with no need of unfolding as first obligatory step (22-25). 
Despite the identification of unfolding-independent aggregation pathways, the molecular 
mechanisms and the structural and stability determinants that promote aggregation from 
native-like states are not yet fully understood. As a consequence, an in-depth understanding of 
the biochemistry and biophysics of the native-like aggregation process upon glycation will be 
crucial to disclose fundamental mechanisms underlying these diseases as well as to further 
develop therapeutic strategies. 
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In the present work we have focused our attention on cytochrome c, a protein recently 
used as a model to study protein aggregation (26). Model proteins offer several advantages as 
they are abundant and inexpensive, and their biophysics have been well characterized. The 
mechanistic principles gathered from model proteins can lead to hypotheses about how 
glycation triggers protein aggregation that can later be tested with disease-related proteins, 
which most of the time are difficult to work with. Among several model proteins available for 
biophysical studies, cytochrome c is excellent because it is highly soluble, and its ready 
production facilitates experiments requiring the large quantities of protein necessary to detect 
and characterize early aggregation intermediates. These features are paramount advantages 
for performing a detailed characterization of methylglyoxal effect on the protein aggregation 
process. 
In this study, we show that cytochrome c is converted into native-like aggregates upon 
methylglyoxal glycation, and that partial unfolding represents an off-pathway to aggregation. 
Circular dichroism (CD) experiments and kinetic model discrimination demonstrate that 
formation of glycated cytochrome c aggregates is thermodynamically and kinetically favored. 
 
Results 
 
Characterization of cytochrome c glycation sites by mass spectrometry 
 
The detection of cytochrome c glycation and assignment of modified amino acid 
residues were performed by mass spectrometry after trypsin digestion. A comparative analysis 
of peptide mass spectra from the glycated and unmodified cytochrome c reveals major 
differences with several new peptides appearing exclusively in the glycated cytochrome c 
(Figure 1A and Table I). These new peaks can be caused by the occurrence of miscleavages 
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associated with defined mass increases of specific MAGE. Since only lysine and arginine 
residues are irreversibly modified, tryptic digestion of glycated proteins would then produce 
peptides with at least one miscleavage associated with a defined mass increase that is 
characteristic of a specific MAGE. For example, the new m/z peak at 1404.727 may correspond 
to the cytochrome c peptide 90-100 (TEREDLIAYLK) with m/z 1350.726 plus 54 Da, a mass 
increase characteristic of a hydroimidazolone modification. Likewise, the new peak at m/z 
1532.821 may correspond to the cytochrome c peptide 89-100 (KTEREDLIAYLK) or the peptide 
90-101 (TEREDLIAYLKK), with the exact same mass of 1478.821, plus a MGH modification (54 
Da mass increment). To unequivocally confirm these data, MS/MS experiments, using collision-
induced dissociation (CID), were performed to provide sequence information. When using the 
CID fragmentation technique, bond breakage mainly occurs through the peptide bond leading 
to b-ions (when the charge is retained by the amino-terminal fragment) or y-ion (when it is 
retained by the carboxy-terminal fragment). Thus, if an amino acid residue is modified, the 
particular y and complementary b ions, which encompasses the modification, will have the 
particular amino acid mass value plus 54.018 Da for hydroimidazolone. With the peptide with 
m/z of 1404.727 TERMGHEDLIAYLK, we clearly observed the b3 ion that corresponds to a TER 
with 54 Da increase of MGH-modified arginine residue (Figure 1B). All other identified b ions 
show the same mass increment. The detection of y9 ion with a mass increase of 54 Da further 
confirms the glycation of R92 with the formation of a hydroimidazolone (Figure 1B). Likewise, 
the MS/MS data in figure 1C further confirms the glycation of R-92. In addition, the sequence 
information gathered for this peptide allowed the identification of peptide KTERMGHEDLIAYLK 
(89-100) instead of peptide TERMGHEDLIAYLKK (90-101), both composed by the same amino 
acid, hence having the exact same molecular mass.  
From this analysis, only R-92 was found to be glycated with the formation of the MAGE 
hydroimidazolone. No lysine modification was detected in our experimental conditions. It is 
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worth mention that upon cytochrome c digestion and subsequent analysis of the tryptic 
digests, high sequence coverage (between 70 and 80 %) was obtained. 
 
Structural characterization of the glycated cytochrome c species 
To investigate the effects of methylglyoxal-induced glycation on cytochrome c 
aggregation, samples of native and glycated cytochrome c at two different incubation times 
were analyzed by size exclusion chromatography (figure 2). Cytochrome c appears at time 0 as 
a single molecular species, with an apparent molecular mass of 12.9 kDa (elution volume – 
12.96 ml) (figures 2A and 2B). The native cytochrome c monomer is stable in solution during 
the time of analysis. In contrast, SEC elution profiles of glycated protein reveal an increasing 
complexity of post-glycation cytochrome c forms with the emergence of four new main 
species. These species show apparent molecular masses consistent with the dimeric, trimeric 
and tetrameric forms of cytochrome c (figure 2B). Moreover, another molecular species 
appears to be present at a higher elution volume (figure 2B, fraction U). The SDS-PAGE analysis 
reveals that the U fraction of cytochrome c has the same electrophoretic mobility of 
cytochrome c monomer (figure 2C). This result discards the idea of protein fragments and 
suggests that the U fraction is in fact a monomeric form of glycated cytochrome c. 
To evaluate the secondary structure of the different species of post-glycation 
cytochrome c, far-UV circular dichroism (CD) was used. Figure 3A shows the CD spectra of the 
native cytochrome c together with the monomeric, dimeric and trimeric forms of glycated 
protein, at 25 ºC and physiological ionic strength and pH. A direct analysis of the CD spectra 
shows that the secondary structure content of both native and glycated forms of cytochrome c 
is very similar. The spectral minima at 208 and 222 nm and a positive band bellow 200 nm, 
which dominates all spectra, are characteristic of α-helical structures (27). Nevertheless, CD 
spectra of aggregates show minimal differences when compared to monomers. Aggregates 
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show no loss in secondary structure, but a slight readjustment of secondary structural 
elements distribution in relation to monomeric forms. CD spectra deconvolution of native and 
glycated species using the CDSSTR algorithm (28), allowed determination of the secondary 
structure contents presented in Table II. This analysis confirmed the mainly α-helical content of 
native and glycated cytochrome c. Still, the analysis of CD spectra of the dimeric and trimeric 
forms of glycated cytochrome c revealed an increase in β-sheet content with a corresponding 
loss of α–helix and β–turns. CD spectra deconvolution of native cytochrome c also shows the 
presence of a small fraction of β-sheet content. Although not detected either by X-ray 
diffraction or by NMR, Calvert and colleagues have observed a similar feature by FTIR (29). The 
CD spectra of the monomeric form of cytochrome c with a higher retention time (U fraction) 
shows no secondary regular structural elements (figure 3B), consistent with the appearance of 
an unfolded monomeric form of glycated cytochrome c. This new populated state of 
monomeric protein species shows that cytochrome c glycation causes cytochrome c unfolding 
and aggregation. 
To evaluate alterations on the three-dimensional structure resultant of structural 
changes at secondary level, tryptophan intrinsic fluorescence was used. Tryptophan has an 
emission maxima ranging from 320 to 355 nm depending on the polarity of the local 
environment. Hence, protein fluorescence may be used as a diagnostic tool to probe the 
conformational state of a protein. Figure 3C shows an overlay of the fluorescence spectra 
obtained with native cytochrome c and the glycated monomeric, dimeric and unfolded species. 
Fluorescence spectra show that no shift in native cytochrome c fluorescence emission λmax 
occurs, when compared with the monomeric and dimeric forms of glycated cytochrome c. 
These results indicate that the tryptophan environment is not affected by glycation or by 
aggregation, which suggests that the three-dimensional structure of cytochrome c is preserved 
in these processes. Nevertheless, a red-shift in fluorescence emission λmax for the unfolded 
species is observed, showing that tryptophans are in a very polar micro-environment. This is 
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expected in an open conformation of the polypeptide chain, confirming the unfolded nature of 
this species. 
 
Conformational stability of cytochrome c forms 
To understand thermodynamically how glycation induces aggregation, we characterized 
the conformational stability of the glycated monomeric and dimeric forms of cytochrome c and 
compared to the native protein. Protein conformational stability can be accessed by analysing 
the dependence of the ellipticity values at 222 nm on guanidinium hydrochloride 
concentration. Native cytochrome c unfolds by a two-state model (M ↔ U) (30), without 
evidence regarding glycation-induced species. For glycated cytochrome c forms there are 
several possible unfolding pathways. We hypothesized that unfolding could occur in the 
presence or in the absence of intermediates and that for the dimer, the final unfolded form 
can be a dimer or a monomer. Thus, unfolding of the monomeric glycated cytochrome c can be 
described by a two-state M ↔ U or by a three-state model M ↔ I ↔ U, while the dimeric 
glycated cytochrome c can be described by one of the following five models: M ↔ U; D2 ↔ I2 
↔ 2U; D2 ↔ 2I ↔ 2U and D2 ↔ I2 ↔ U2. To discriminate among these unfolding pathways, 
SEC experiments in the presence of increasing amounts of GdnHCl were performed (figure 4A 
and 4B). In the 1.5-2.5 M GdnHCl concentration range, the glycated monomer and dimer are in 
the transition state between native and unfolded forms (figure 4C). Figure 4 A shows a 
progressive and direct conversion of the dimer to the unfolded form, suggesting that unfolding 
intermediates are not populated to any measurable extent. Retention times decrease 
progressively with the increase of denaturant concentration because the denaturant promotes 
a partial expansion of the hydrodynamic radius of the protein in both dimeric and monomeric 
forms. When compared with the cytochrome c monomer (figure 4 B), apparently both 
monomeric and dimeric species unfold to the same unfolded species, suggesting that the 
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unfolding pathway of the glycated dimer can be described by a D2 ↔ 2U model. The total 
absence of an unfolded dimeric form shows that aggregates are non-covalent and that cross-
links are not observable in this denaturant concentration range. Glycated monomer also shows 
a direct conversion from the native to the unfolded form and no unfolding intermediates are 
observed, suggesting that glycated monomer unfolds through a two-state model (figure 4 B). 
In order to establish the thermodynamic parameters for native and glycated cytochrome 
c (monomer and dimer), monomeric species were analysed according to a two-state unfolding 
model M ↔ U, while dimeric species was analysed considering equation 1 that describes an 
approximation to determine the effective ΔG (31). Both fits were made using the linear 
extrapolation method (32) in a non-linear least squares fitting procedure and yielded values for 
ΔGº(H2O), the conformational stability, and m, the dependence of ΔGº on denaturant 
concentration. Table III shows the values obtained from the curves in figure 4C for ΔGº(H2O), m 
and Cm, the denaturant concentration at the midpoint of the unfolding transition. The 
magnitude of ΔGº(H2O) for the native cytochrome c fits well within typical values obtained for 
denaturation of similar size proteins (33) and the value of m explains the rapid transition 
between the two well defined states represented in native cytochrome c curve. When 
glycation occurs, a significant decrease on cytochrome c conformational stability from 8.1 ± 0.6 
to 3.1 ± 0.6 kCal.mol
-1
 is observed. Additionally, Cm also suffers a decrease from 2.5 ± 0.4 to 2.2 
± 0.8 M, confirming the reduction of conformational stability upon glycation. 
When compared to the glycated monomer, glycated dimer shows an increase of 
conformational stability from 3.1 ± 0.6 to 8.4 ± 1.3 kCal.mol
-1
 (table III). These results on 
conformational stability of native and glycated forms of cytochrome c may thermodynamically 
elucidate the aggregation process observed in size exclusion chromatography (figure 2). 
Methylglyoxal irreversibly decreases cytochrome c stability, possibly mainly due to loss of 
positive charges at the surface, forcing the modified monomer to aggregate, which leads to the 
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formation of a more stable species. The decrease in conformational stability of cytochrome c 
upon glycation is balanced with an increase of conformational stability gain upon aggregation. 
 
Kinetic analysis of cytochrome c aggregation 
Besides aggregation, cytochrome c undergoes a conversion to a partially unfolded form. 
Thus, despite the native-like structure of post-glycated cytochrome c aggregates, it is possible 
that the partially unfolded form participates in the aggregation pathway. To clarify the 
aggregation mechanism, a kinetic analysis of time course obtained by SEC was performed. We 
investigated two possible cytochrome c aggregation models.  The first model assumes that 
folded monomers (M) reversibly convert to partially unfolded monomers (U), and that the 
aggregation proceeds through folded monomers; with dimers (D), trimers (T3) and tetramers 
(T4) formed by addition of M. Thus, the reaction pathway for model 1 is: 
 
 
 
 
 
 
 
 
The differential equations describing the kinetic pathway for model 1 are: 
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where ki is the forward and k-i is the reverse rate constant for each reaction. The second model 
assumes that aggregates are formed by continuous addition of unfolded monomers: 
 
 
 
 
 
 
The equations for model 2 are: 
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The concentration of each species was measured over time by SEC, and parameter 
estimates were obtained by fitting the two kinetic models to the experimental data using the 
software package Athena Visual Studio. Initially, we assumed that all four reactions were 
reversible, and each model had 8 parameters. However, in some cases the fitted reverse rate 
constant was negative or had large confidence intervals, indicating that the parameters were 
not required. Therefore the model equations were modified to eliminate these rate constants 
and the number of parameters was reduced to five and six for models 1 and 2, respectively. A 
summary of the fitted parameters is given in Table IV.  There are several points worth noting 
about the parameter estimates for model 2. 
 
1. We were unable to calculate a 95% confidence interval for k2, thus leaving the 
parameter as indeterminate. This suggests that k2 is not well known. However, k2 was 
not removed from the model since it is required for the production of dimers in model 
2.  
2. k2 and k-2 are two to three orders of magnitude higher than some of the other 
parameter estimates. The concentration of U at early time points is small and the large 
k2 is needed to account for the increase in dimer concentration. However, at later time 
points as the concentration of U increases, a large k-2 is needed to counter the effect of 
the large k2.  
 
The AIC scores for model 1 and model 2 were calculated and are summarized in table V. 
Model 1 has a lower residual sum of squares and a lower AIC score compared to model 2 and 
therefore is the preferred model.  Both models are able to simulate the concentration profiles 
relatively well (Figure 5), although the deviation from the experimental data for U is noticeably 
worse for model 2.  However, the uncertainty in parameter k2 as well as the large value for 
parameters k2 and k-2 in model 2 indicate that model 2 is not an adequate model for describing 
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the aggregation process. Considering these results, model 1 is a better candidate model to 
explain the aggregation pathway of cytochrome c, meaning that the aggregation mechanism 
occurs through a direct non-covalent interaction of post-glycated monomeric cytochrome c 
subunits and the partial unfolding of cytochrome c is off-pathway. 
 
Discussion 
 
One of the key issues to elucidate the pathogenesis of protein deposition diseases is the 
mechanism by which such proteins are converted from their native-state into high molecular 
aggregates. At least two major pathways have been identified to date (1). In some cases 
aggregation starts from fully or partially unfolded conformational states (1). These can be 
either native states of intrinsically unstructured proteins or non-native states formed by a 
folded protein through an unfolding event. This unfolding event leads to the exposure of 
aggregation prone peptide segments, which are able to form intermolecular interactions, thus 
triggering aggregation (1). More recently, a different aggregation pathway has been identified 
where aggregation of normally globular proteins can occur, starting from conformational 
states directly accessible from native states via thermal fluctuations, mutations, cis-trans 
proline isomerization or post-translational modifications, but in all cases with no need of 
transition across the major energy barrier for unfolding (34). They can be either transiently 
formed conformations accessible through fluctuations of the native state (35) or 
conformational states permanently populated due to post-translational modifications or other 
events, i. e. states with a thermodynamic higher energy than that of the fully folded state (36). 
In the current work we have investigated the effects of methylglyoxal-modification of 
cytochrome c on structural, stability and aggregation properties. When methylglyoxal reacts 
with proteins, a process involving multi-step non-enzymatic reactions between the carbonyl 
groups of methylglyoxal and free amino groups in protein molecules leads to the formation of 
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irreversible AGEs. The side chains of arginine and lysine residues and N-terminal amino group 
are the available targets for glycation. To characterize post-glycation cytochrome c modified 
residues, MALDI-TOF/TOF was used. Mass spectrometry data showed that only arginine 92 is 
modified by methylglyoxal with the formation of a hydroimidazolone adduct. This result is 
consistent with known preferred arginine modification by methylglyoxal (37).  
Recent reports have shown that methylglyoxal-modification of different proteins leads 
to the formation and stabilization of small and soluble aggregated species that retain native-
like structure (13; 14). Here we show that, once glycated with methylglyoxal, cytochrome c 
starts an aggregation process wherein the formed aggregates retain native-like structure. In 
spite of maintaining the α–helical fold typical of cytochrome c, glycated cytochrome c 
aggregates have a slight increase of β-sheet content as judged by CD. This increase in β-sheet 
content may be justified by the aggregation process, since it is known that β-sheet produces a 
better environment for intermolecular interactions through hydrogen bonding (38). 
Additionally, tryptophan intrinsic fluorescence did not show any differences between native 
and glycated (monomer and dimer) cytochrome c species, suggesting that the three-
dimensional structure of cytochrome c remains unchanged during aggregation. 
Our data suggest that the most profound effect of glycation is the reduction of 
conformational stability. It is likely that the pronounced decrease of ΔG(H2O) from 8.1 ± 0.6 to 
3.1 ± 0.6 kCal.mol
-1
 is due to the loss of positive charge(s) at the protein’s surface, which can 
decrease the protein’s pI, increase hydrophobicity and slightly change protein core interaction, 
judging by the decrease of m value. A reduction in protein stability is a step to populate 
unfolded species due to a lower Ku (unfolding constant) and to aggregation, principally when 
new hydrophobic segments are exposed to solvent. Aggregation leads to increasing 
conformational stability, possibly by minimizing the number of hydrophobic side-chains 
exposed to the solvent through the formation of intermolecular hydrogen bonds in the β-sheet 
segments. 
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We wondered whether the native monomeric form of glycated cytochrome c is the 
aggregation unit, or if partial unfolding is required for aggregation. Kinetic modeling of 
cytochrome c aggregation time course data coupled with model discrimination allowed us to 
distinguish between two different models. Although both models were able to capture the 
kinetic data reasonably well, our analysis indicated that the primary means of cytochrome c 
aggregation is by continuous addition of monomeric glycated cytochrome c to form dimers, 
trimers and tetramers. The results also suggest that the partial unfolding of monomeric 
cytochrome c is reversible, but that subsequent aggregation steps are essentially irreversible.    
Based on our results, we propose a model for native-like aggregation of methylglyoxal-
glycated proteins where the aggregation occurs due to loss of conformational stability of the 
modified protein. Consequently, an aggregation process is started directly through monomer 
addition in a process that is thermodynamically and kinetically favoured. Interestingly, the 
glycated cytochrome c unfolded species is an off pathway byproduct, a clear difference from 
the amyloidogenic aggregation pathways (figure 6). These results can apparently be extended 
to the aggregation behaviour of amyloidogenic proteins upon glycation. In fact both insulin 
and α-synuclein, which are involved in amyloid diseases, show less amyloid fibril formation 
after glycation and both retain significantly the native three-dimensional structure during the 
aggregation process. In conclusion, glycation of amyloidogenic proteins can lead to a shift from 
an amyloidogenic pathway to a native-like aggregation through a process that is 
thermodynamically and kinetically favoured. 
 
Material and Methods 
Protein preparation and glycation 
Horse heart cytochrome c (Sigma) was dissolved in 50 mM potassium phosphate buffer, 
pH 7.0 and 150 mM of NaF to a final concentration of 10 mg.ml
-1
. For the methylglyoxal-
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derived glycation of cytochrome c, the protein solution was incubated with 10 mM 
methylglyoxal (a kind gift from Dr. Carlos Cordeiro, Centro de Química e Bioquímica, FCUL, 
Lisbon, Portugal) at 37 ºC in sterile conditions. Control samples were treated in the same way 
but without methylglyoxal addition. Aliquots were collected in sterile conditions at defined 
times from 0 to 7 days and immediately analysed. 
 
Characterization of cytochrome c glycation by methylglyoxal using mass spectrometry and 
dot-blot analysis 
Methylglyoxal-derived glycation of cytochrome c was characterized by mass 
spectrometry. Control and glycated cytochrome c was separated by 1D-polyacrylamide gel 
electrophoresis (1D-PAGE) and in gel trypsin digestion was performed as described (39). 
Briefly, gel protein bands were washed in milliQ water and destained in 50% acetonitrile (ACN) 
and subsequently with 100% ACN. Cys residues were reduced with 10 mM DTT and alkylated 
with 50 mM iodoacetamide. Gel pieces were vacuum dried and rehydrated in digestion buffer 
containing 50 mM NH4HCO3 and 6.7 ng/µL of trypsin (Sigma, proteomics grade, Promega) at 4 
ºC. Upon rehydration, the supernatant was discarded and 20 µL of 50 mM NH4HCO3 were 
added. Digestions were allowed to proceed at 37 ºC overnight (16-18 hours). After digestion, 
the remaining supernatant was removed and stored at -20 ºC until analysis. The obtained 
peptide mixture was purified and concentrated by solid-phase extraction using home-made R2 
Pore microcolumns (Applied Biosystems) as previously described (39). Peptide mixture was  
eluted directly onto the MALDI target plate with 0.5 µl of α-CHCA matrix (5 mg.ml
-1
) prepared 
in 50% (v/v) acetonitrile with 0.1% (v/v) formic acid. Sample peptides were analysed in a 
MALDI-TOF-TOF mass spectrometer 4800 plus (Applied Biosystems) in positive reflectron 
mode for peptide mass determination. The mass spectrometer was externally calibrated using 
des-Arg-Bradykinin (904.468 Da), angiotensin 1 (1296.685 Da), Glu-Fibrinopeptide B (1570.677 
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Da), ACTH (1-17) (2093.087 Da), and ACTH (18-39) (2465.199) (4700 Calibration Mix, Applied 
Biosystems). Mass spectra were collected in a result-independent acquisition mode, typically 
using 1000 laser shots per spectrum and a fixed laser intensity of 3500V.  
 The identification of glycated amino acid residues was performed as described (40; 41). 
Briefly, a glycated cytochrome c peptide should be exclusively present in the MS spectrum of 
the modified protein and have a miscleavage associated with a defined mass increment of a 
specific MAGE (72 Da for the lysine specific MAGE carboxyethyl-lysine (CEL) and 54, 80 and 144 
Da for the arginine-specific MAGE hydroimidazolones (MGH), argpyrimidine and 
tetrahydropirimidine respectively). Tandem MS sequence information allowed the unequivocal 
identification of MAGE-modified peptides and also assignment of specific modified amino acid. 
The peptides of interest (i.e., having a mass consistent with the mass increment of the 
modifications by methylglyoxal) were selected for MS/MS experiments using Collision Induced 
Dissociation (CID), with 1 kV collision energy and an air pressure of 106 torr. Two thousand 
laser shots were collected for each MS/MS spectrum using a fixed laser intensity of 4500 V. 
Raw data were generated by the 4000 Series Explorer Software v3.0 RC1 (Applied Biosystems). 
The MS/MS data were analysed by DataExplorer
TM
 software V4.5 (Applied Biosystems) 
combined with manual inspection of the assigned sequence. 
 
Cytochrome c aggregation 
Aggregation of cytochrome c upon glycation by methylglyoxal was monitored by size 
exclusion chromatography (SEC). Samples were analysed by SEC at incubation times of 0 and 7 
days, after filtration with a 0.2 μm Whatman filter. SEC was performed with a HPLC Jasco PU-
2080 Plus isocratic pump with an UV detector JASCO 2075. The mobile phase was 5 mM 
sodium phosphate buffer pH 7 with 150 mM NaF. Separation was achieved on a molecular 
exclusion analytical column (Amersham-Pharmacia Superdex™ 75 10/300 GL) at a flow rate of 
0.4 ml/min and the eluting peaks were monitored at 280 nm. The monomeric and unfolded 
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forms of glycated cytochrome c were also separated by SDS-PAGE on a Bio-Rad Mini-Protean 3 
system, using 15 % separation gel and a 4 % stacking gel. Proteins were stained with Comassie 
Brilliant Blue (42). 
 
Structural characterization of cytochrome c species 
After 7 days incubation with methylglyoxal, glycated and control samples of cytochrome 
c were separated and individually collected by SEC, as described, and analysed by circular 
dichroism (CD) and fluorescence spectroscopy. Secondary structure analysis was performed by 
far-UV CD in a Jasco J810 spectropolarimeter equipped with a temperature control unit Julabo 
F25. Far UV (185-260 nm) CD spectra were recorded with 0.1 cm (linear) path length quartz 
cuvette. For each spectrum, three scans were averaged. Protein concentration was previously 
determined by absorbance at 410 nm (ε410=1.06x10
5
 M
-1
 cm
-1
) in a UV-Visible 
spectrophotometer Jasco V-530. For protein secondary structure estimation, CD spectra were 
deconvoluted using CDSSTR (28) deconvolution algorithm on Dichroweb (43; 44). CD spectra of 
the samples’ buffer were recorded and subtracted from the protein spectra. 
Tertiary structure changes were probed by tryptophan red shift fluorescence analysis. 
Fluorescence spectra were measured in a Perkin Elmer LS50B instrument equipped with a 
Julabo F12 temperature control unit, in quartz cuvettes with 1 cm excitation light path. 
Intrinsic protein fluorescence emission was recorded between 300 and 400 nm with excitation 
at 280 nm, an increment of 0.5 nm, an integration time of 1 s and 7 nm slits for both excitation 
and emission. 
 
Determination of the unfolding pathway for glycated cytochrome c dimer 
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The presence of intermediates in the unfolding pathway of the glycated cytochrome c 
dimer was evaluated by SEC in denaturing conditions. To capture eventual unfolding 
intermediates, glycated monomer and dimer were first separated and collected by SEC in the 
above-mentioned non-denaturing conditions. Samples (100 μl) were then incubated in 5 mM 
phosphate buffer pH 7 with 150 mM NaF supplemented with guanidinium hydrochloride 
(GdnHCl) at the concentrations of 1.5, 2.0 and 2.5 M for 2 days. This range of GdnHCl 
concentrations is in the unfolding transition phase of the glycated cytochrome c dimer. After 
protein denaturation, samples were again analysed by SEC. During separation, GdnHCl was 
present in the mobile phase at sample’s concentration. 
 
Conformational stability of cytochrome c species 
Conformational stability of glycated and non-glycated cytochrome c species was 
measured by CD in GdnHCl-induced protein unfolding experiments at 25 ºC after 48 hours 
incubation. GdnHCl-induced denaturation was found to be reversible for all cytochrome c 
forms studied, as judged by SEC experiments. CD denaturation curves were constructed using 
ellipticity values at 222 nm. Monomeric and dimeric species were analysed according to a two-
state unfolding model  M ↔ U and D2 ↔ 2U respectively using the linear extrapolation 
method (32) in a non-linear least squares fitting procedure. This yielded values for ∆Gº(H2O), 
the conformational stability, and m, the dependence of ∆Gº on denaturant concentration. Cm, 
the denaturant concentration at the midpoint of the unfolding transition was calculated as
 
( ) mGCm /OHº 2∆= . Denaturation curves for monomeric species were analysed considering 
the equation developed by Santoro & Bolen (45; 46). For dimeric species, ∆Gº(H2O) was 
determined from the estimation of the effective ∆G, as described (31). Briefly, the equilibrium 
denaturation curve of the glycated cytochrome c dimer was analysed using the same equation 
as for the monomeric species and the effective ∆G was calculated considering equation 1. 
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where ΔGeff(H2O) represents the effective ∆G; m/n is the m-value of a monomeric unit of the n-
mer and R(n) is a residual function of n, the oligomeric state of the protein. R(n) is responsible 
for the differences in ΔGeff(H2O) values between different oligomeric states of a same protein. 
Assuming that in non-denaturing conditions the fraction of unfolded protein will be minimal (a 
reasonable assumption for a stable protein under aqueous condition), ΔGº(H2O) of the 
cytochrome c dimer can be directly related to ΔGeff(H2O) using equation 2 (31). 
 
( )
( ) ( )122 ln
º −+
∆
=∆ nteff nC
n
RT
n
OHG
OHG       (2) 
 
where ΔG
º
(H2O) is the conformational stability of the protein and Ct is the total protein molar 
concentration in monomer units. In equation 2, ΔG
º
(H2O)/n is the ΔG
º
(H2O) per monomer unit 
(47). This term is concentration-independent and represents an intrinsic property of the 
protein. In contrast, the second term depends only on the concentration and oligomeric state 
of the protein, and represents the loss of entropy involved in the oligomerization process (31). 
Parameters were obtained by fitting the derived equations to the experimental data by non-
linear regression using the Solver add-on for Microsoft Excel. 
 
Model discrimination and estimation of the kinetic constants of aggregation 
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The kinetic parameters of glycated cytochrome c aggregation were determined by time-
course analysis. Time-course data were obtained by SEC as described above. Samples were 
analysed after different incubation periods ranging from 0 to 400 hours. In this analysis, two 
different models were tested. In model 1, the glycated monomeric cytochrome c is the 
aggregation unit and the partially unfolded form of cytochrome c is off-pathway. In model 2, it 
is assumed that glycated cytochrome c primary unfolds to a partially unfolded form that 
subsequently initiates the aggregation process. The model parameters were regressed using 
the software program Athena Visual Studio 14.2 (Athena Visual Software, Naperville, IL).  
Athena Visual Studio provides the user with a Windows based interface for inputs into 
equation solving and parameter estimation programs.  Athena utilizes an implicit integrator 
package, DDAPLUS, for solving initial-boundary value problems described by sets of mixed 
differential and algebraic equations (48; 49). Parameter estimation from multi-response data is 
provided by non-linear least squares regression using the GREGPLUS algorithm (50; 49) while 
confidence intervals on parameters are calculated from the covariance matrix. Model 
equations and concentration data for each species (unfolded monomers, monomers, dimers, 
trimers and tetramers) were programmed into Athena along with initial guesses for the 
parameter values. 
The Akaike Information Criteria (AIC) was used to determine the best model. The AIC is a 
measure of the relative goodness of fit of a model and is derived via information theory (51). 
AIC is calculated from the weighted residual sum of squared errors Φresid, the number of 
parameters nparam and the number of data points ndata (equation 3). The model with the lowest 
AIC value is preferred. The value of AIC for a given model increases as Φresid and nparam 
increases. Therefore, the AIC discourages overparameterization as increasing the number of 
parameters will result in a higher AIC score. The weighted residual sum of squares was 
determined by first weighting the data points. Weighting the data ensures that each data point 
contributes equally to the total sum of squares. The weighting was performed by assuming 
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that the error (σ) associated with each data point was 10% of the value of the data point itself.  
The weighted residual sum of squares was calculated using equation 4 where yi and f(xi) refer 
to the measured concentration and predicted concentration respectively. 
 
     (3) 
                                                                                        (4) 
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 Tables 
 
Table I - Assignment of glycated amino acid residues. In all cases, the observed peptide mass has a mass increment 
specific of a methylglyoxal-derived AGE modification. The specific MAGE are indicated in the table and the modified 
amino acid residue is highlighted in the peptide sequence. For these three glycated cytochrome c peptides, tandem 
MS data confirms the glycated arginine 92. (MGH – hydroimidazolone).  
Observed 
mass (Da) 
Theoretical 
mass (Da) 
Peptide sequence 
Mass 
Increase (Da) 
MAGE 
Glycated 
residue 
1404.727 1350.726 
TEREDLIAYLK 
(90-100) 
54.001 MGH R92 
1532.821 1478.821 
KTEREDLIAYLK 
(89-100) 
54.000 MGH R92 
1660.911 1606.916 
KKTEREDLIAYLK 
(88-100) 
53.995 MGH R92 
 
 
 
Page 29 of 42
 Table II – Distribution of the structural element fractions obtained by deconvolution of CD spectra using CDSSTR 
algorithm available on Dichroweb. The NRMSD parameter represents the normalized root mean square deviance.  
Structural element α-Helix β-Sheet β-Turns 
Unordered 
structure 
NRMSD 
Native Cytochrome c 0.32 0.08 0.18 0.41 0.024 
Glycated Monomer 0.32 0.08 0.19 0.40 0.021 
Glycated Dimer 0.25 0.19 0.15 0.40 0.056 
Glycated Trimer 0.24 0.19 0.15 0.41 0.057 
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 Table III – Thermodynamic parameters from GdnHCl unfolding studies of native and glycated cytochrome c. 
Parameters were obtained by a direct fit of the model equations to experimental data in figure 4C. ΔGº(H2O), 
protein conformational stability; m, the dependence of ΔGº on denaturant concentration; Cm, the denaturant 
concentration at the midpoint of the unfolding transition.  
 
ΔGº(H2O) 
(kcal·mol
-1
) 
m 
(kcal·mol
-1
.M
-1
) 
Cm 
(M) 
Native 
Cytchrome c 
8.1 ± 0.6 3.2 ± 0.3 2.5 ± 0.4 
Glycated 
Monomer 
3.1 ± 0.6 1.4 ± 0.2 2.2 ± 0.8 
Glycated 
Dimer 
8.4 ± 1.3 - 2.2 ± 0.5 
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 Table IV: Fitted parameter values and their 95% confidence intervals obtained by regression to experimental data. A 
tilde (~) between brackets indicate an indeterminate parameter. NR = not required 
 
k1 
(h
-1
) 
k-1 
(h
-1
) 
k2 
(mM
-1
 h
-1
) 
k-2 
(h
-1
) 
k3 
(mM
-1
 h
-1
) 
k4 
(mM
-1
 h
-1
) 
Model 
1 
1.6 ± 0.4 
 x 10
-3
 
5.7 ± 2.3 
 x 10
-3
 
6.9 ± 0.4 
 x 10
-4
 
NR 
3.2 ± 0.2 
 x 10
-3
 
4.5 ± 0.5 
 x 10
-3
 
Model 
2 
3.4 ± 0.4 
 x 10
-3
 
1.1 ± 0.2 
 x 10
-2
 
2.6 (~) 
 
6.4 ± 1.3 
 x 10
-1
 
1.6 ± 0.2 
 x 10
-2
 
2.2 ± 0.4 
 x 10
-3
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 Table V: The Akaike Information Criteria (AIC) score for models 1 and 2.  
 nparam ndata 
Weighted 
Φresid 
AIC score 
Model 1 5 45 2.17 x 10
2 
1.94 
Model 2 6 45 7.73 x 10
2 
3.29 
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 Figure Legends 
 
Figure 1 - Detection of MAGE-modified cytochrome c peptides and location of glycated amino 
acids by mass spectrometry. A - Representative section of the MALDI-TOF/TOF spectra of 
peptides from non-modified and glycated cytochrome c. New m/z peaks, absent from the 
control, are clearly detected in the mass spectra of the glycated cytochrome c (highlighted in 
red). These new m/z values correspond to a cytochrome c peptide plus the mass increment 
characteristic of a hydroimidazolone modification (54 Da). These peptides were analyzed by 
MS/MS, confirming the glycation of the arginine residue 92. B - Tandem MS spectrum of a 
glycated cytochrome c peptide with m/z 1404.7269, showing the y and b fragment ions. The 
detected fragment ions arise from the amino acid sequence TEREDLIAYLK, with a 
hydroimidazolone modification on the arginine residue. C - Tandem MS spectrum of a glycated 
cytochrome c peptide with m/z 1532.8164, showing the y and b fragment ions. The detected 
fragment ions arise from the amino acid sequence KTEREDLIAYLK, with a hydroimidazolone 
modification on the arginine residue. 
 
Figure 2 – Size exclusion chromatograms of native and glycated cytochrome c. A – Native 
cytochrome c; B – Cytochrome c after incubation with methylglyoxal. All samples have the 
same protein concentration (0.85 mM) and were eluted with a flow rate of 0.4 ml/min. The 
labels in chromatograms have the following meaning: T4 – Glycated tetramer; T3 – Glycated 
trimer; D – Glycated dimer; M – Glycated monomer; U – High elution volume species.  
To understand the nature of the U species, a SDS-PAGE gel was performed comparing the 
migration of the U and M species (C). The gel shows an identical migration for both species 
discarding the possibility of cytochrome c fragments and suggesting that the U species are in 
fact an unfolded form of cytochrome c. 
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Figure 3 - Structural characterization of the different species of native and glycated 
cytochrome c. A – Secondary structure of native cytochrome c (black), glycated monomer 
(blue), dimer (red) and trimer (green) evaluated by far-UV CD. B – Far-UV CD spectra of the 
high elution volume species (U) showing absence of secondary structure elements. C – Tertiary 
structure of native cytochrome c (black solid) and glycated monomer (blue), dimer (red) and 
high elution volume species (U) (black dash) evaluated by intrinsic fluorescence emission. All 
experiments were made in 5 mM phosphate buffer pH 7 supplemented with 150 mM NaF at 
25 ºC after 7 days incubation with methylglyoxal. Native cytochrome c was submitted to the 
same conditions without the presence of methylglyoxal. 
 
Figure 4 – Determination of the conformational stability of native and glycated cytochrome c 
species. A - To determine the unfolding mechanism of cytochrome c glycated species, glycated 
dimer was collected from SEC in non-denaturing conditions and incubated with 1.5 (black), 2 
(dark grey) and 2.5 M (light grey) of GdnHCl at 25 ºC for 2 days. Then aliquots were analysed 
by SEC and eluted with the same incubation buffer. The chromatograms show no unfolding 
intermediates. B – Comparison of the unfolding pathways of the glycated monomer (blue) and 
glycated dimer (red). Both species were previously separated and collected from SEC in non-
denaturing conditions, incubated with 2 M GdnHCl for 2 days and then analysed by SEC 
containing GdnHCl in the mobile phase. The chromatograms show that both species unfold to 
the same denatured monomeric form and no intermediates are detected to any measurable 
extent. C - Guanidinium hydrochloride equilibrium denaturation curves of native cytochrome c 
(black – primary axis), glycated monomer (blue – secondary axis) and glycated dimer (red – 
secondary axis) at pH 7 and 25 ºC monitored by ellipticity at 222 nm. For the monomeric forms 
of cytochrome c, the equation used represents a two-state unfolding model (M↔U), while for 
the dimeric form, ΔGº(H2O) was determined considering the effective ΔG (31) and applying a 
two-state unfolding model (D2↔2U). The curves are non-linear least squares fits to the 
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equations representing the entire denaturation curve and using a linear extrapolation method 
to the experimental circular dichroism data. The insets are the residues plots. 
 
Figure 5 - Model simulations using parameter estimates from Athena Visual Studio for model 1 
(solid line) and model 2 (dashed line). Different models were fitted to experimental time 
course data obtained by SEC, describing the variation of each glycated cytochrome c species 
along time. Model 1 assumes that the aggregation proceeds through folded monomers with 
dimers, timers and tetramers formed by monomer addition. Model 2 assumes that larger 
aggregate species are formed by continuous addition of unfolded monomers.  A - 
Concentration of monomers. B - Concentration of Unfolded monomers. C - Concentration of 
dimers. D - Concentration of trimers. E - Concentration of tetramers. 
 
Figure 6 - Molecular model for cytochrome c aggregation upon methylglyoxal glycation. The 
native protein is primarily irreversibly glycated by methylglyoxal forming a glycated monomer. 
This monomer, which has a reduced stability, can follow two different pathways. It can 
undergo a rapid equilibrium with a partial unfolded monomeric form, or it can irreversibly go 
through an aggregation pathway by the sequential addition of glycated monomers. 
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Figure 1 - Detection of MAGE-modified cytochrome c peptides and location of glycated amino acids by mass 
spectrometry. A - Representative section of the MALDI-TOF/TOF spectra of peptides from non modified and 
glycated cytochrome c. New m/z peaks, absent from the control, are clearly detected in the mass spectra of 
the glycated cytochrome c (highlighted in red). These new m/z values correspond to a cytochrome c peptide 
plus the mass increment characteristic of a hydroimidazolone modification (54 Da). These peptides were 
analyzed by MS/MS, confirming the glycation of the arginine residue 92. B - Tandem MS spectrum of a 
glycated cytochrome c peptide with m/z 1404.7269, showing the y and b fragment ions. The detected 
fragment ions arise from the amino acid sequence TEREDLIAYLK, with a hydroimidazolone modification on 
the arginine residue. C - Tandem MS spectrum of a glycated cytochrome c peptide with m/z 1532.8164, 
showing the y and b fragment ions. The detected fragment ions arise from the amino acid sequence 
KTEREDLIAYLK, with a hydroimidazolone modification on the arginine residue.  
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Figure 2 – Size exclusion chromatograms of native and glycated cytochrome c. A – Native cytochrome c; B – 
Cytochrome c after incubation with methylglyoxal. All samples have the same protein concentration (0.85 
mM) and were eluted with a flow rate of 0.4 ml/min. The labels in chromatograms have the following 
meaning: T4 – Glycated tetramer; T3 – Glycated trimer; D – Glycated dimer; M – Glycated monomer; U – 
High elution volume species.  
To understand the nature of the U species, a SDS-PAGE gel was performed comparing the migration of the U 
and M species (C). The gel shows an identical migration for both species discarding the possibility of 
cytochrome c fragments and suggesting that the U species are in fact an unfolded form of cytochrome c.  
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Figure 3 - Structural characterization of the different species of native and glycated cytochrome c. A – 
Secondary structure of native cytochrome c (black), glycated monomer (blue), dimer (red) and trimer 
(green) evaluated by far-UV CD. B – Far-UV CD spectra of the high elution volume species (U) showing 
absence of secondary structure elements. C – Tertiary structure of native cytochrome c (black solid) and 
glycated monomer (blue), dimer (red) and high elution volume species (U) (black dash) evaluated by 
intrinsic fluorescence emission. All experiments were made in 5 mM phosphate buffer pH 7 supplemented 
with 150 mM NaF at 25 ºC after 7 days incubation with methylglyoxal. Native cytochrome c was submitted 
to the same conditions without the presence of methylglyoxal.  
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Figure 4 – Determination of the conformational stability of native and glycated cytochrome c species. A - To 
determine the unfolding mechanism of cytochrome c glycated species, glycated dimer was collected from 
SEC in non-denaturing conditions and incubated with 1.5 (black), 2 (dark grey) and 2.5 M (light grey) of 
GdnHCl at 25 ºC for 2 days. Then aliquots were analysed by SEC and eluted with the same incubation 
buffer. The chromatograms show no unfolding intermediates. B – Comparison of the unfolding pathways of 
the glycated monomer (blue) and glycated dimer (red). Both species were previously separated and 
collected from SEC in non-denaturing conditions, incubated with 2 M GdnHCl for 2 days and then analysed 
by SEC containing GdnHCl in the mobile phase. The chromatograms show that both species unfold to the 
same denatured monomeric form and no intermediates are detected to any measurable extent. C - 
Guanidinium hydrochloride equilibrium denaturation curves of native cytochrome c (black – primary axis), 
glycated monomer (blue – secondary axis) and glycated dimer (red – secondary axis) at pH 7 and 25 ºC 
monitored by ellipticity at 222 nm. For the monomeric forms of cytochrome c, the equation used represents 
a two-state unfolding model (M↔U), while for the dimeric form, ∆Gº(H2O) was determined considering the 
effective ∆G (31) and applying a two-state unfolding model (D2↔2U). The curves are non-linear least 
squares fits to the equations representing the entire denaturation curve and using a linear extrapolation 
method to the experimental circular dichroism data. The insets are the residues plots.  
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Figure 5 - Model simulations using parameter estimates from Athena Visual Studio for model 1 (solid line) 
and model 2 (dashed line). Different models were fitted to experimental time course data obtained by SEC, 
describing the variation of each glycated cytochrome c species along time. Model 1 assumes that the 
aggregation proceeds through folded monomers with dimers, timers and tetramers formed by monomer 
addition. Model 2 assumes that larger aggregate species are formed by continuous addition of unfolded 
monomers.  A - Concentration of monomers. B - Concentration of Unfolded monomers. C - Concentration of 
dimers. D - Concentration of trimers. E - Concentration of tetramers.  
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Figure 6 - Molecular model for cytochrome c aggregation upon methylglyoxal glycation. The native protein is 
primarily irreversibly glycated by methylglyoxal forming a glycated monomer. This monomer, which has a 
reduced stability, can follow two different pathways. It can undergo a rapid equilibrium with a partial 
unfolded monomeric form, or it can irreversibly go through an aggregation pathway by the sequential 
addition of glycated monomers.  
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